Page last updated: 2024-12-07
bis(trimethoxysilyl)ethane
Description
Bis(trimethoxysilyl)ethane, also known as BTSE, is a bifunctional organosilane used as a coupling agent in various applications. It acts as a bridge between organic and inorganic materials, enhancing adhesion and improving mechanical properties. BTSE is synthesized via the reaction of trichlorosilane with ethylene glycol in the presence of a catalyst. Research on BTSE focuses on its potential for improving the properties of composites, coatings, and adhesives. Its ability to create strong bonds between different materials makes it valuable in areas like polymer-ceramic composites, nanocomposites, and sol-gel processes. The study of BTSE involves exploring its reactivity, hydrolysis, and polymerization behavior in various reaction conditions, as well as its impact on the performance of materials.'
bis(trimethoxysilyl)ethane: used as surface modifier of metal vie the sol-gel process and dip coating [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 87627 |
| SCHEMBL ID | 35673 |
| MeSH ID | M0506947 |
Synonyms (29)
| Synonym |
|---|
| 1,2-bis(trimethoxysilyl)ethane , |
| 3,3,6,6-tetramethoxy-2,7-dioxa-3,6-disilaoctane |
| 2,7-dioxa-3,6-disilaoctane, 3,3,6,6-tetramethoxy- |
| dow corning x1-6145a |
| 1,2-ethylenebis(trimethoxysilane) |
| einecs 242-285-6 |
| 1,4-disilabutane, 1,1,1,4,4,4-hexamethoxy- |
| hexamethoxydisilylethane |
| brn 1776976 |
| 1,2-bis(trimethoxysilyl)ethane, 96% |
| trimethoxy(2-trimethoxysilylethyl)silane |
| 4-04-00-04265 (beilstein handbook reference) |
| bis(trimethoxysilyl)ethane |
| 18406-41-2 |
| ethylenebis(trimethoxysilane) |
| B2927 |
| AKOS015901929 |
| SCHEMBL35673 |
| JCGDCINCKDQXDX-UHFFFAOYSA-N |
| DTXSID6066369 |
| FT-0696940 |
| mfcd00053672 |
| 1,2-bis(trimethoxylsilyl)ethane |
| AMY6766 |
| D95407 |
| AS-76038 |
| 168259-18-5 |
| 1,1,1,4,4,4-hexamethoxy-1,4-disilabutane |
| LJZ836PHD3 |
Research
Studies (11)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 31.89
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 31.89 (24.57) | | Research Supply Index | 2.56 (2.92) | | Research Growth Index | 4.46 (4.65) | | Search Engine Demand Index | 36.02 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 1 (9.09%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (90.91%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |